Anika Therapeutics (ANIK) Tops Q2 EPS by 32c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $16.02 +4.30%
Revenue Growth %: +3.5%
Financial Fact:
Net income: 0.59
Today's EPS Names:
CRMT, PKE, More
Revenue Growth %: +3.5%
Financial Fact:
Net income: 0.59
Today's EPS Names:
CRMT, PKE, More
Join SI Premium – FREE
Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.76, $0.32 better than the analyst estimate of $0.44. Revenue for the quarter came in at $33.46 million versus the consensus estimate of $27.2 million.
For earnings history and earnings-related data on Anika Therapeutics (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- HSBC sees more upside in Intel stock on server CPU opportunity
- Vertex to acquire Crinetics Pharmaceuticals for $10 billion
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
